Grapefruit juice improves glycemic control but exacerbates metformin-induced lactic acidosis in non-diabetic rats

Methods and Findings in Experimental and Clinical Pharmacology

Volumn 31, Issue 9, 2009, Pages 563-570

  Owira, P M O ^a   Ojewole, J A O ^a  

^a UNIVERSITY OF KWAZULU NATAL   (South Africa)

Author keywords

Blood glucose; Diabetes mellitus; Grapefruit juice; Lactic acidosis; Metformin

Indexed keywords

GLUCOSE; INSULIN; LACTIC ACID; METFORMIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE EXACERBATION; DISEASE MODEL; DRUG BLOOD LEVEL; DRUG TISSUE LEVEL; FOOD; FOOD DRUG INTERACTION; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE; GLYCEMIC CONTROL; GRAPEFRUIT JUICE; INSULIN BLOOD LEVEL; LACTATE BLOOD LEVEL; LACTIC ACIDOSIS; LIVER; MALE; NONHUMAN; RAT; THERAPY EFFECT; TREATMENT OUTCOME;

ACIDOSIS, LACTIC; ANIMALS; BEVERAGES; BLOOD GLUCOSE; CITRUS PARADISI; GLUCOSE TOLERANCE TEST; HYPOGLYCEMIC AGENTS; INSULIN; MALE; METFORMIN; RATS; RATS, WISTAR;

EID: 75749134939     PISSN: 03790355     EISSN: None     Source Type: Journal    
DOI: 10.1358/mf.2009.31.9.1435463     Document Type: Article

References (44)

1. Kiani, J., Imam, S.Z. Medicinal importance of grapefruit juice and its interaction with various drugs. Nutr J 2007, 6: 33.
2. So, S.V., Guthrie, N., Chambers. A.F., Moussa, M., Carol, K.K. Inhibition of human cancer cell proliferation and delay of mammary cell tumorigenesis by flavonoids and citrus juices. Nutr Cancer 1996, 26(2): 167-81.
3. Guthrie, N., Carol, K.K. Inhibition of mammary cancer by citrus flavonoids. Adv Exp Med Biol 1998, 439: 227-36.
4. Takanaga, H., Ohnishi, A., Matsuo, H. et al. Pharmacokinetic analysis of felodipine-grapefruit juice interaction based on an irreversible enzyme inhibition model. Br J Clin Pharmacol 2000, 49(1): 49-58.
5. Kupferschmidt, H.H., Fattinger, K.E., Ha, H.R., Follath, F., Krähenbühl, S. Grapefruit enhances the bioavailability of the HIV protease inhibitor saquinavir in man. Br J Clin Pharmacol 1998, 45(4): 355-9.
6. Pillai, U., Muzaffar, J., Sen, S., Yancey, A. Grapefruit juice and verapamil: a toxic cocktail. South Med J 2009, 102(3): 308-9.
7. Dahan, A., Amidon, G.L. Grapefruit juice and its constituents augment colchicine intestinal absorption: potential hazardous interaction and the role of p-glycoprotein. Pharm Res 2009, 26(4): 883-92.
8. Strauch, K., Lutz, U., Bittner, N., Lutz, W.K. Dose-response relationship for the pharmacokinetic interaction of grapefruit juice with dextromethorphan investigated by human urinary metabolite profiles. Food Chem Toxicol 2009, 47(8): 1928-35.
9. Bailey, D.G., Malcolm, J., Arnold, O., Spence, J.D. Grapefruit juice-drug interactions. Br J Clin Pharmacol 1998, 46(2): 101-10.
10. Paine, M.F., Widmer, W.W., Pusek, S.N. et al. Further characterization of a furanocoumarin-free grapefruit juice on drug disposition: studies with cyclosporine. Am J Clin Nutr 2008, 87(4): 863-71.
11. Bailey, D.G., Dresser, G.K. Interactions between grapefruit juice and cardiovascular drugs. Am J Cardiovasc Drugs 2004, 4(5): 281-97.
12. Fujioka, K., Greenway, F., Sheard, J., Ying, Y. The effects of grapefruit juice on weight and insulin resistance: relationship with metabolic syndrome. J Med Food 2006, 9(1): 49-54.
13. Florida Department of citrus: History of dieting, Florida, Department of Citrus, Lakeland FL, 2003.
14. [No authors listed]. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group. Lancet 1998, 352(9131): 854-65.
15. Douek, I.F., Allen, S.E., Ewings, P., Gale, E.A., Bingley, P.J. Continuing metformin when starting insulin in patients with Type 2 diabetes: a double-blind randomized placebo-controlled trial. Diabet Med 2005, 22(5): 634-40.
16. Holstein, A., Stumvoll, M. Contraindications can damage your health-is metformin a case point? Diabetologia 2005, 48(12): 2454-9.
17. Fisman, E.Z., Tenenbaum, A. A cardiologic approach to non-insulin antidiabetic pharmacotherapy in patients with heart disease. Cardiovasc Diabetol 2009, 8: 38.
18. McFadden, C. Why check metformin levels? Crit Care Med 2009, 37(7): 2312-3.
19. Bruijstens, L.A., van Luin, M., Buscher-Jungerhans, P.M., Bosch, F.H. Reality of severe metformin-induced lactic acidosis in the absence of chronic renal impairment. Neth J of Med 2008, 66(5): 185-90.
20. Howlett, H.C.S., Bailey, C.J. A risk-benefit assessment of metformin in type 2 diabetes mellitus. Drug Saf 1999, 20(6): 489-503
21. Seidowsky, A., Nseir, S., Houdret, N., Fourrier, F. Metformin- associated lactic acidosis: a prognostic and therapeutic study. Crit Care Med 2009, 37(7): 2191-6.
22. Arroyo, A.M., Walroth, T.A., Mowry, J.B., Kao, L.W. The MALAdy of Metformin Poisoning: Is CVVH the Cure? Am J Ther 2009, [Epub ahead of print] doi: 10.1097/MJT.0b013e318197eab6.
23. Wang, D.S., Kusuhara, H., Kato, Y., Jonker, J.W., Schinkel, A.H., Sugiyama, Y. Involvement of organic cation transporter 1 in the lactic acidosis caused by metformin. Mol Pharmacol 2003, 63(4): 844-8.
24. Riesenman, P.J., Braithwaite, S.S., Cairns, B.A. Metformin-associated lactic acidosis in a burn patient. Journal Burn Care Res 2007, 28(2): 342-7.
25. Dawson, D., Conlon, C. Case study: metformin-associated lactic acidosis: could orlistat be relevant? Diabetes Care 2003, 26(8): 2471-2.
26. Lalau, J.D., Race, J.M. Lactic acidosis in metformin-treated patients. Prognostic value of arterial lactate levels and plasma metformin concentrations. Drug Saf 1999, 20(4): 377-84.
27. Brown, J.B., Pedula, K., Barzilay, J., Herson, M.K., Latare, P. Lactic acidosis rates in type 2 diabetes. Diabetes Care 1998, 21(10): 1659-63.
28. Lorke, D. A new approach to practical acute toxicity testing. Arch Toxicol 1983, 54(4): 275-87.
29. Lilja, J.J., Niemi, M., Fredrikson, H., Neuvonen, P.J. Effects of clarithromycin and grapefruit juice on the pharmacokinetics of glibenclamide. Br J Clin Pharmacol 2007, 63(6): 732-40.
30. Ribeiro, I.A., Ribiero, M.H.L. Naringin and naringenin determination and control in grapefruit juice by a validated HPLC method. Food Control 2008, 19(4): 432-8.
31. Yu. J., Wang, L., Walzem, R.L., Miller, E.G., Pike, L.M., Patil, B.S. Antioxidant activity of citrus limonoids, flavonoids, and coumarins. J Agric Food Chem 2005, 53(6): 2009-14.
32. Paine, M.F., Widmer, W.W., Pusek, S.N., Beavers, K.L., Criss, A.B., Snyder, J ., Watkins, P.B. Further characterization of a furanocoumarin-free grape-fruit juice on drug disposition: studies with cyclosporine. Am J Clin Nutr 2008, 87(4): 863-71.
33. Bailey, D.G., Arnold, J.M., Munoz, C., Spence, J.D. Grapefruit juice-felodipine interaction: mechanism, predictability, and effects of naringin. Clin Pharmacol Ther 1993, 53(6): 637-42.
34. Purushotham, A., Tian, M., Belury, M.A. The citrus fruit flavonoid naringenin suppresses hepatic glucose production from Fao hepatoma cells. Mol Nutr Food Res 2008, 53(2): 300-7
35. Zhou, G., Myers, R., Li, Y. et al. Role of AMP-activated protein kinase in mechanism of metformin action. J Clin Invest 2001, 108(8): 1167-74.
36. Abbud, W., Habinowski, S., Zhang, J.Z. et al. Stimulation of AMP-activated protein kinase (AMPK) is associated with enhancement of Glut1-mediated glucose transport. Arch Biochem Biophys 2000, 380(2): 347-52.
37. Jung, U.J., Lee, M.K., Jeong, K.S., Choi, M.S. The hypoglycemic effects of hesperidin and naringin are partly mediated by hepatic glucose-regulating enzymes in C57BL/KsJ-db/db mice. J Nutr 2004, 134(10): 2499-503.
38. Ortiz-Andrade, R.R., Sánchez-Salgado, J.C., Navarrete- Vázquez, G. et al. Antidiabetic and toxicological evaluations of naringenin in normoglycaemic and NIDDM rat models and its implications on extra-pancreatic glucose regulation. Diabetes Obes Metab 2008, 10(11): 1097-104.
39. Bailey, C.J., Wilcock, C., Scarpello, J.H. Metformin and the intestine. Diabetologia 2008, 51(8): 1552-3.
40. Wilcock, C. Bailey, C.J. Sites of metformin-stimulated glucose metabolism. Biochem Pharmacol 1990, 39(11): 1831-4.
41. Bailey, C.J., Wilcock, C., Day, C. Effect of metformin on glucose metabolism in the splanchnic bed. Br J Pharmacol 1992, 105(4): 1009-13.
42. Lalau, J.D., Lacroix, C., Compagnon, P. et al. Role of metformin accumulation in metformin-associated lactic acidosis. Diabetes Care 1995, 18(6): 779-84.
43. Stades, A.M., Heikens, J.T., Erkelens, D.W., Holleman, F., Hoekstra, J.B. Metformin and lactic acidosis: cause or coincidence? A review of case reports. J Intern Med 2004, 255(2): 179-87.
44. Wang, D.S., Jonker, J.W., Kato, Y., Kusuhara, H., Schinkel, A.H., Sugiyama, Y. Involvement of organic cation transporter 1 in hepatic and intestinal distribution of metformin. J Pharmacol Exp Ther 2002, 302(2): 510-5.